BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dlugos D, Worrell G, Davis K, Stacey W, Szaflarski J, Kanner A, Sunderam S, Rogawski M, Jackson-Ayotunde P, Loddenkemper T, Diehl B, Fureman B, Dingledine R; Epilepsy Benchmark Stewards. 2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects. Epilepsy Curr 2016;16:192-7. [PMID: 27330452 DOI: 10.5698/1535-7511-16.3.192] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Barker-Haliski M, Steve White H. Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening. Neuropharmacology 2020;167:107750. [PMID: 31469995 DOI: 10.1016/j.neuropharm.2019.107750] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
2 Traynelis SF, Dlugos D, Henshall D, Mefford HC, Rogawski MA, Staley KJ, Dacks PA, Whittemore V, Poduri A; National Institutes of Neurological Disorders and Stroke (NINDS)/American Epilepsy Society (AES) Epilepsy Research Benchmark Stewards. Epilepsy Benchmarks Area III: Improved Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects. Epilepsy Curr 2020;20:23S-30S. [PMID: 31965829 DOI: 10.1177/1535759719895279] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Luiz Gomes A Júnior, Dimitrova Tchekalarova J, Atanasova M, da Conceição Machado K, de Sousa Rios MA, Paz MFCJ, Găman MA, Găman AM, Yele S, Shill MC, Khan IN, Islam MA, Ali ES, Mishra SK, Islam MT, Mubarak MS, da Silva Lopes L, de Carvalho Melo-Cavalcante AA. Anticonvulsant effect of anacardic acid in murine models: Putative role of GABAergic and antioxidant mechanisms. Biomed Pharmacother 2018;106:1686-95. [PMID: 30170356 DOI: 10.1016/j.biopha.2018.07.121] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
4 Marsh ED, Whittemore V, Leenders M, Poduri A; American Epilepsy Society Epilepsy Research Benchmark Stewards Committee. The 2021 Epilepsy Research Benchmarks-Respecting Core Principles, Reflecting Evolving Community Priorities. Epilepsy Curr 2021;21:389-93. [PMID: 34924844 DOI: 10.1177/15357597211023712] [Reference Citation Analysis]
5 Poduri A, Whittemore VH. The Benchmarks: Progress and Emerging Priorities in Epilepsy Research. Epilepsy Curr 2020;20:3S-4S. [PMID: 31868039 DOI: 10.1177/1535759719888646] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Luna-Munguia H, Zestos AG, Gliske SV, Kennedy RT, Stacey WC. Chemical biomarkers of epileptogenesis and ictogenesis in experimental epilepsy. Neurobiol Dis 2019;121:177-86. [PMID: 30304705 DOI: 10.1016/j.nbd.2018.10.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]